Approaches to male hypogonadism in primary care
Authors:
Open Access
- 12 February 2017
- journal article
- other
- Published by Wolters Kluwer Health in The Nurse Practitioner
- Vol. 42 (2) , 32-37
Abstract
Evidence suggests that providers are not adhering to current testosterone replacement therapy guidelines when treating male hypogonadism. Understanding the diagnosis and management of this condition is further complicated by conflicting recommendations among available guidelines. NPs must select and follow the best guideline recommendations available to optimally treat male hypogonadism.Keywords
This publication has 34 references indexed in Scilit:
- Ascertainment of Testosterone Prescribing Practices in the VAMedical Care, 2015
- Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and StrokeJournal of Urology, 2015
- Testosterone Replacement Therapy and Cardiovascular Risk: A ReviewThe World Journal of Men's Health, 2015
- Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested updateThe Aging Male, 2013
- Trends in Androgen Prescribing in the United States, 2001 to 2011JAMA Internal Medicine, 2013
- Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trialsBMC Medicine, 2013
- How to help the aging male? Current approaches to hypogonadism in primary careThe Aging Male, 2012
- Diagnosing and treating testosterone deficiency in different parts of the world: changes between 2006 and 2010The Aging Male, 2011
- Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly MenNew England Journal of Medicine, 2010
- A practical guide to male hypogonadism in the primary care settingInternational Journal Of Clinical Practice, 2010